Oncogenic KRAS signalling in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is almost universally fatal. The annual number of deaths equals the number of newly diagnosed cases, despite maximal treatment. The overall 5-year survival rate of <5% has remained stubbornly unchanged over the last 30 years, despite tremendous efforts in p...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Eser, S, Schnieke, A, Schneider, G, Saur, D
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2014
Gaiak:
Minireview
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4150259/
https://ncbi.nlm.nih.gov/pubmed/24755884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.215
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak